GlassScriptPhysician profile
John P Girod
NPI 1902016405
$2,646.99
in general payments reported to CMS, 2019-2025
25 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $184 · 2021: $396 · 2022: $344 · 2023: $285 · 2024: $491 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,456.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $494.35 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Novartis Pharmaceuticals Corporation | $373.18 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $345.57 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $228.04 | 2021-2025 | Mitraclip |
| Pfizer INC. | $201.16 | 2020-2024 | |
| Heartflow, INC. | $168.57 | 2025 | |
| Sanofi-Aventis U.S. LLC | $128.52 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $117.45 | 2021-2023 | Verquvo |
| Edwards Lifesciences Corporation | $107.92 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $62.78 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $52.53 | 2021 | |
| Amgen INC. | $50.63 | 2021-2023 | Repatha |
| Novo Nordisk INC | $49.78 | 2025 | Ozempic, Wegovy |
| Siemens Medical Solutions USA, INC. | $47.75 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.76 | 2022-2023 | Lifevest |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $24.22 | 2021 | |
| Cvrx, INC. | $22.46 | 2023 | Barostim Neo System |
| Irhythm Technologies, INC. | $20.56 | 2024 | Zio Xt Patch, Zio Monitor |
| Lundbeck LLC | $19.68 | 2021 | |
| Corindus INC. | $19.01 | 2019 | |
| Shockwave Medical, INC | $17.64 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.55 | 2023 | |
| Scpharmaceuticals INC. | $15.91 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.52 | 2024 | Jardiance |
| Preventice Services, LLC | $15.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Girod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.